News about "drug discovery"

Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration

Fauna Bio has achieved a target designation milestone in its obesity discovery collaboration, advancing a novel target identified through its Convergence AI platform.

Drug Discovery | 20/03/2026 | By News Bureau

Dalriada Drug Discovery, Topos Bio Partner to Advance AI-Driven Drug Discovery for Intrinsically Disordered Proteins

Dalriada Drug Discovery and Topos Bio collaborate to accelerate drug discovery for intrinsically disordered proteins using AI, mass spectrometry and proteomics to improve experimental validation and therapeutic development.

Drug Discovery | 18/03/2026 | By News Bureau |  142

Roche Boosts AI Muscle with Nvidia Chip Expansion to Accelerate Drug Discovery

Swiss pharma major Roche has significantly expanded its artificial intelligence (AI) capabilities by deploying thousands of advanced GPUs from Nvidia, marking one of the largest AI infrastructure investments in the pharmaceutical sector.

Drug Discovery | 17/03/2026 | By Darshana |  121

Syngene Partners with Johns Hopkins University for Early Drug Discovery

The collaboration between Syngene International and John Hopkins University is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research.

Drug Discovery | 13/02/2026 | By News Bureau |  135

Illumina Completes USD 350 Million Acquisition of SomaLogic to Expand Multiomics and Proteomics Capabilities

Illumina has completed its USD 350 million acquisition of SomaLogic, strengthening its multiomics portfolio and expanding large-scale proteomics capabilities to accelerate drug discovery and improve patient outcomes.

Drug Discovery | 02/02/2026 | By News Bureau |  880

FAR Biotech Sets Up Operations in Wisconsin, Expands QuantumAI Programmes

Far Biotech, part of the Johnson & Johnson Innovation JLABS ecosystem, is advancing a quantum mechanics-based, AI-powered approach to drug discovery as it expands operations in Madison, Wisconsin.

Drug Discovery | 22/01/2026 | By News Bureau |  198

Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals with Pfizer

Adaptive Biotechnologies has signed two immune receptor licensing agreements with Pfizer, covering a T-Cell Receptor (TCR) discovery collaboration in rheumatoid arthritis and access to Adaptive’s proprietary TCR-antigen datasets for immunology R&D.

Drug Discovery | 16/12/2025 | By News Bureau |  214

IIT Madras and Ohio State Researchers Develop AI Framework That Mimics Chemical Synthesis for Drug Discovery

Researchers from the Indian Institute of Technology Madras (IIT Madras) and Ohio State University have developed an advanced artificial intelligence framework that replicates real-world chemical synthesis to accelerate drug discovery.

Drug Discovery | 06/11/2025 | By Darshana |  333

Syngene International Invests in Peptide Laboratory and Advanced Automation

Syngene International has set up a dedicated peptide laboratory equipped with advanced automation technologies to accelerate hit-to-lead timelines. The investment enhances the company’s integrated drug discovery and development capabilities, reinforcing its position as a leading partner for end-to-end research solutions.

Drug Discovery | 16/10/2025 | By Dineshwori |  304

IRBM Expands Functional Genomics Platform to Boost Early Drug Discovery

The platform integrates CRISPR-based methodologies, screening capabilities, cell engineering, and advanced molecular and cellular analysis to drive both target discovery and validation.

Drug Discovery | 05/04/2025 | By Aishwarya |  326